During the past decade, The First Affiliated Hospital of University of South China conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The First Affiliated Hospital of University of South China" #1 sponsor was "Sun Yat-sen University" with 3 trials, followed by "The First Affiliated Hospital of University of South China" with 3 trials sponsored, "Second Xiangya Hospital of Central South University" with 2 trials sponsored, "Shenzhen Hornetcorn Bio-technology Company, LTD" with 2 trials sponsored and "Wei-Hai Xu" with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The First Affiliated Hospital of University of South China" #1 collaborator was "Peking Union Medical College Hospital" with 3 trials as a collaborator, "The First Affiliated Hospital of University of South China" with 3 trials as a collaborator, "Beijing Hospital" with 2 trials as a collaborator, "China-Japan Union Hospital, Jilin University" with 2 trials as a collaborator and "Fujian Medical University Union Hospital" with 2 trials as a collaborator. Other collaborators include 79 different institutions and companies that were collaborators in the rest 82 trials.

According to Clinical.Site data, the most researched conditions in "The First Affiliated Hospital of University of South China" are "Acute Coronary Syndrome" (2 trials), "Acute Ischemic Stroke" (2 trials), "Coronary Artery Disease" (2 trials), "Hepatocellular Carcinoma" (2 trials) and "Kidney Calculi" (2 trials). Many other conditions were trialed in "The First Affiliated Hospital of University of South China" in a lesser frequency.

Most popular intervention types in "The First Affiliated Hospital of University of South China" are "Drug" (16 trials), "Procedure" (6 trials), "Biological" (2 trials), "Combination Product" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Human umbilical cord mesenchymal stem cells" (2 trials), "Placebo" (2 trials), "Amoxicillin Capsules" (1 trials), "Analgesia-first minimal sedation" (1 trials) and "Antihypertensive treatment" (1 trials). Other intervention names were less common.

The vast majority of trials in "The First Affiliated Hospital of University of South China" are 25 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "The First Affiliated Hospital of University of South China". 1 are not yet recruiting, 9 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in The First Affiliated Hospital of University of South China, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in The First Affiliated Hospital of University of South China, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 6 trials that are defined as “Not Applicable".